Methusalem Podcast

Methusalem Podcast with Niklas Anzinger

41 min · 23. Feb. 2026
Episode Methusalem Podcast with Niklas Anzinger Cover

Beschreibung

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Methusalem Podcast-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

5 Folgen

Episode Methusalem Podcast with Niklas Anzinger Cover

Methusalem Podcast with Niklas Anzinger

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

23. Feb. 202641 min